drugset / Trial / NCT02108886

Pilot Study Testing a New Strategy for Management of Spontaneous Preterm Birth

NCT02108886

Phase 2 Unknown 100 enrolled University of Sherbrooke
RandomizedParallel-groupTriple-blindTreatment

Summary

Preterm birth is a major public health problem, and actual treatments are not very efficient. The purpose of this study is to test the efficiency of a combined use of Montelukast and Nifedipine to treat preterm labor. Investigators aim to reduce uterine contractions more efficiently than with the use of Nifedipine only.

Timeline

Start
2011-12
Primary completion
2014-07
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Montelukast Other / unclassified 10 mg

Indications

No indication recorded.